Tu donación es 100% deducible de impuestos.
Referencias del cáncer de origen primario desconocido
American Cancer Society. Cancer Facts and Figures 2016. Atlanta, Ga: American Cancer Society; 2016.
American Cancer Society. Cancer Facts and Figures 2017. Atlanta, Ga: American Cancer Society; 2017.
Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567-578.
Glover KY, Varadhachary GR, Lenzi R, et al. Unknown primary cancer. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Kastan MB, McKenna WG. eds. Clinical Oncology. 4th ed. Philadelphia, Pa; Elsevier; 2008: 2057-2074.
Greco FA, Hainsworth JD. Cancer of unknown primary site. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011:2033-2051.
Hainsworth JD, Spigel DR, Farley C, et al. Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network. J Clin Oncol. 2007;25:1747-1752.
Jerusalem G, Rorive A, Ancion G, et al. Diagnostic and therapeutic management of carcinoma of unknown primary: radio-imaging investigations. Ann Oncol. 2006;17 Suppl 10:x168-176.
Mintzer DM, Warhol M, Martin AM, et al. Cancer of unknown primary: changing approaches. A multidisciplinary case presentation from the Joan Karnell Cancer Center of Pennsylvania Hospital. Oncologist. 2004;9:330-338.
National Cancer Institute Physician Data Query (PDQ). Carcinoma of Unknown Primary: Treatment. 4/11/2014. Accessed at www.cancer.gov/cancertopics/pdq/treatment/unknownprimary/HealthProfessional on June 25, 2014.
National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology: Occult primary. Version 3.2014. Accessed at www.nccn.org on June 25, 2014.
Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Onc/Hem. 2005;54:243-250.
Seve P, Sawyer M, Hanson J, et al. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site. Cancer. 2006;106:2058-2066.
Varadachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer. 2004;100:1776-1785.
Nuestra labor es posible gracias a generosos donantes como usted.
Done ahora para que podamos continuar brindando acceso a información crítica sobre el cáncer, recursos y apoyo y así mejorar las vidas de las personas con cáncer y sus familias.
